| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/27/2001 | CN1300743A Polypeptide-tyrosinase 14 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300742A Polypeptide-kringle protein 8 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300741A Polypeptide-bromo structure domain 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300740A Polypeptide-actin 41 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300739A Polypeptide-ribosome 39 protein 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300736A Polypeptide-DBH and PAM 20 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300734A Polypeptide-beta-transducin 41 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1067726C Monoclonal antibody for recognizing interstitial cell surface antigen |
| 06/26/2001 | US6252087 Complexing with a protein |
| 06/26/2001 | US6252055 Generating immunoglobulins; filter immunoglobulin solution through membrane, cycle filtrate through membrane, recover immunoglobulin |
| 06/26/2001 | US6252054 Immobilization of SH group-containing compounds in the presence of a sulfite-containing antioxidant |
| 06/26/2001 | US6252052 Antibodies which bind to NY-ESO-1 cancer associated proteins, and hybridomas which produce these antibodies |
| 06/26/2001 | US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor |
| 06/26/2001 | US6252050 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
| 06/26/2001 | US6252047 Polypeptide associated with the diagnosis, treatment and prevention of cancer; antitumor agents |
| 06/26/2001 | US6252044 Riboflavin synthase polypeptide; for the controlled biosynthesis of riboflavin; for screening bactericides; for prevention of infection |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251920 Administering tamoxifen or its structural analogs for prophylaxis and therapy of atherosclerosis, thrombosis, myocardial infarction and stroke |
| 06/26/2001 | US6251865 Insulin-like growth factor agonist molecules |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251675 Modifying cell by delivering mutant rev gene having mutation from amino acid position 68 to 90 of the wild-type protein; intracellular immunization |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251630 Polynucleotide encoding member of ribonuclease family of defined amino acid sequence; diagnosis; bacteriostats; bactericides; vaccines; treatment of otitis media, pneumonia, conjunctivitis, bacteremia, meningitis, sinusitis, and others |
| 06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
| 06/26/2001 | US6251613 Method for detecting anti-GADII antibody and method for diagnosing cancer using said detection method |
| 06/26/2001 | US6251612 Hybridoma; cheap and sensitive monitoring of water pollution |
| 06/26/2001 | US6251603 Evaluating cancer in humans; detect preferential gene expression in tumor, mix sample with antibodies which bind preferential protein, count amount of protein, an amplified protein value indicates adjustment in cancer classification |
| 06/26/2001 | US6251593 Regulatory sequences which are induced by maltose; for use in development of fungicides; for use in control of cell propagation |
| 06/26/2001 | US6251590 Differential Qualitative screening |
| 06/26/2001 | US6251419 Membrane system for controlled tissue regeneration in cases of diseases of the periodontium |
| 06/26/2001 | US6251404 Collecting a sample of a naturally occurring isolated virus such as the iowa strain, and a naturally occuring strain that causes lesions in colostrum deprived piglets, treating to deactivate virus and admixing with carrier |
| 06/26/2001 | US6251397 Purified polypeptides encoded by open reading frames (orf's) of a highly virulent strain of the virus as determined by its ability to induce lung lesions in 51.9% of colostrum-deprived piglets; vaccines |
| 06/26/2001 | US6251395 Inhibiting macrophage infiltration at the site of a central nervous system injury such as spinal cord injury by administering an anti-integrin subunit alpha-d monoclonal antibody |
| 06/26/2001 | US6251393 Conformation-specific anti-von Willebrand Factor antibodies |
| 06/26/2001 | US6251389 Human nucleotide pyrophosphohydrolase-2 |
| 06/26/2001 | US6251387 Topoisomerase I |
| 06/21/2001 | WO2001045122A1 Reagents, methods and kits for detecting bacillus thuringiensis proteins |
| 06/21/2001 | WO2001044815A1 Helicobacter pylori antigens in blood |
| 06/21/2001 | WO2001044808A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044463A1 Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044438A2 Serological diagnostic method with rickettsia pulicis bacterium |
| 06/21/2001 | WO2001044301A1 Immobilized single domain antigen-binding molecules |
| 06/21/2001 | WO2001044300A2 Brain specific binding members |
| 06/21/2001 | WO2001044299A2 Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |
| 06/21/2001 | WO2001044298A1 Improvement of therapeutic potential of immunoglobulin preparations |
| 06/21/2001 | WO2001044291A2 Polynucleotid encoding the rg1 polypeptide |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001043779A2 Anti-hiv-1 conjugates for treatment of hiv disease |
| 06/21/2001 | WO2001043773A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 06/21/2001 | WO2001043771A1 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory iga's |
| 06/21/2001 | WO2001043770A2 Method for enhancing immune responses in mammals |
| 06/21/2001 | WO2001043767A1 Phosphoglycerate kinase in the treatment of disease |
| 06/21/2001 | WO2001043763A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | WO2001019871A3 Delivery system for antidandruff agent |
| 06/21/2001 | WO2001014535A3 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 06/21/2001 | WO2001013122A3 Method for monitoring beta tubulin isotype modification |
| 06/21/2001 | WO2001013110A3 Detection of isomerised epitopes in autoimmune diseases |
| 06/21/2001 | WO2001011051A3 Chimeric proteins |
| 06/21/2001 | WO2001010911A3 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 06/21/2001 | WO2001007607A8 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 06/21/2001 | WO2001002895A8 System, apparatus, and method for correcting vision using an electro-active lens |
| 06/21/2001 | WO2000078972A8 Regulation with binding cassette transporter protein abc1 |
| 06/21/2001 | WO2000075278B1 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 06/21/2001 | WO2000058472A8 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 06/21/2001 | WO2000014212A9 Novel protein kinase molecules and uses therefor |
| 06/21/2001 | WO1998010795A9 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 06/21/2001 | US20010004456 Cytokine antagonists for the treatment of sensorineural hearing loss |
| 06/21/2001 | DE19961519A1 New nucleic acid encoding plant receptor-like protein kinase, useful for identifying new herbicides and growth regulators |
| 06/21/2001 | DE19957889A1 New nucleic acid encoding triterpenoid-cyclase, useful for producing cyclic triterpenoids and for increasing content of polyunsaturated fatty acids in transgenic organisms |
| 06/21/2001 | CA2394576A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | CA2394574A1 Dna encoding a novel rg1 polypeptide |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394205A1 Reagents, methods and kits for detecting bacillus thuringiensis proteins |
| 06/21/2001 | CA2394160A1 Human oxidoreductase proteins |
| 06/21/2001 | CA2394149A1 Serological diagnostic method with rickettsia pulicis bacterium |
| 06/21/2001 | CA2393869A1 Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| 06/21/2001 | CA2393371A1 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory iga's |
| 06/21/2001 | CA2393292A1 Brain specific binding members |
| 06/21/2001 | CA2392423A1 Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |
| 06/21/2001 | CA2392137A1 Method for enhancing immune responses in mammals |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/21/2001 | CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/20/2001 | EP1108790A2 Novel polynucleotides |
| 06/20/2001 | EP1108784A1 Placental organic anion transporter and gene thereof |
| 06/20/2001 | EP1108435A1 Preventives or remedies for pancreatitis containing il-6 antagonists as the active ingredient |
| 06/20/2001 | EP1108433A2 Combination vaccine for enhancing immunity against brucellosis |
| 06/20/2001 | EP1108068A1 T-type calcium channel |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108034A2 Attenuated salmonella spi2 mutants as antigen carriers |
| 06/20/2001 | EP1108033A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108024A1 Lim domain protein homolog |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |